logo
Plus   Neg
Share
Email

Astec Industries Q1 Adj. EBITDA Declines; Net Sales Down 11.3%

Astec Industries, Inc. (ASTE) reported that its first quarter adjusted EPS of $1.00, increased 53.8% compared to $0.65 from last year; inclusive of $0.42 benefit to EPS attributed to the CARES Act. On average, four analysts polled by Thomson Reuters expected the company to report profit per share of $0.38, for the quarter. Analysts' estimates typically exclude special items. Adjusted EBITDA was $24.3 million, down 4.7% from $25.5 million prior year.

First quarter net sales were $288.8 million, down 11.3% compared to $325.8 million, prior year. Excluding the impact of foreign currency, net sales decreased 10.5%. Analysts expected revenue of $291.45 million for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT